Skip Navigation Links
Home
Products
Events
Resources
Support
Investors
Contact
  

TEMP6.0GPsm.webGraphic.jpg  TinyGastroLogo.jpg
The industry's most advanced absorption, pharmacokinetic, and pharmacodynamic simulation software
SciFiAPSmJewelCase3.jpg  TinyADMETpredLogo.jpg
ADME-Tox property prediction and model-building
NEW! Biorelevant solubility and toxicity models!
SciFiMCSsmJewelCase.jpg

 TinyMedChemLogo.jpg
Advanced data mining and molecule design


TinyDDDJewelCase.jpg   TinyDDDPlusLogo.jpg
Simulation software for in vitro dissolution experiments


Simulations Plus Releases Major Upgrade in ADMET Predictor 5.0
LANCASTER, Calif.--(BUSINESS WIRE)-- Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of simulation and modeling software for pharmaceutical d...
Read More
Simulations Plus Reports Third Quarter FY2010 Financial Results
LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, Inc. (NASDAQ: SLP - News), a leading provider of simulation and modeling software for pharmaceut...
Read More
Third Quarter FY2010 Earnings Release Conference Call and Webinar 
Our CEO, Walt Woltosz, held a conference call Friday, July 16. 2010 to present our financial results for the third quarter of FY2010. To watch the presentation followed by a question and answer session, please go to Inverstors, then Conference Call from our navigation bar above.